Ventricular Assist Device Implant in the Elderly Is Associated With Increased, but Respectable Risk: A Multi-Institutional Study Pavan Atluri, MD, Andrew.

Slides:

Advertisements

Similar presentations

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Advertisements

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Darrell Wu, MD, Matt D. Price, MS, Hiruni S. Amarasekara, MS, Susan Y

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Transcatheter and Surgical Aortic Valve Replacement in Dialysis Patients: A Propensity- Matched Comparison Dale M. Kobrin, BA, Fenton H. McCarthy, MD,

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular.

Combined Heart and Liver Transplantation Can Be Safely Performed With Excellent Short- and Long-Term Results Pavan Atluri, MD, Ann Gaffey, MD, Jessica.

Laura Harvey, MD, Christopher Holley, MD, Samit S

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Video-Assisted Thoracoscopic Left Ventricular Pacing in Patients With and Without Previous Sternotomy Katharine E. Nelson, MBBS, MRCP, Matthew G.D. Bates,

Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation Elizabeth A. Genovese, BS, Mary Amanda.

Predicting Right Ventricular Failure in the Modern, Continuous Flow Left Ventricular Assist Device Era Pavan Atluri, MD, Andrew B. Goldstone, MD, Alex.

Hyde M. Russell, MD, Soraya L. Johnson, BS, Katherine C

Dhaval Chauhan, MD, Alexis K

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

The Impact of Specific Preoperative Organ Dysfunction in Patients Undergoing Aortic Valve Replacement Vinod H. Thourani, MD, Ritam Chowdhury, MD, Rebecca.

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Improved Approach With Subcostal Exchange of the HeartMate II Left Ventricular Assist Device: Difference in On and Off Pump? Ann C. Gaffey, MD, MTR,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Operative Results and Outcomes in Children With Shone's Anomaly

Does Prior Coronary Bypass Surgery Present a Unique Risk for Reoperative Valve Surgery? Andrew Breglio, BS, Anelechi Anyanwu, MD, Shinobu Itagaki, MD,

Matthew L. Williams, MD, Joseph E. Bavaria, MD, Michael A

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Factors Affecting Survival After Mitral Valve Replacement in Patients With Prosthesis– Patient Mismatch Abdulhameed Aziz, MD, Jennifer S. Lawton, MD,

Darrell Wu, MD, Matt D. Price, MS, Hiruni S. Amarasekara, MS, Susan Y

Postoperative Recurrence of Mitral Regurgitation After Annuloplasty for Functional Mitral Regurgitation Lawrence S. Lee, MD, Michael H. Kwon, MD, Marisa.

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Who Do You Say You Are? The Annals of Thoracic Surgery

Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation Ann C.

A “Repair-All” Strategy for Degenerative Mitral Valve Disease Safely Minimizes Unnecessary Replacement Andrew B. Goldstone, MD, Jeffrey E. Cohen, MD,

Clinical and In Vitro Evidence That Subclinical Hemolysis Contributes to LVAD Thrombosis Carlo R. Bartoli, MD, PhD, David Zhang, BSE, Jooeun Kang, BA,

Ross Versus Non-Ross Aortic Valve Replacement in Children: A 22-Year Single Institution Comparison of Outcomes John W. Brown, MD, Parth M. Patel, BS,

Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle Masashi Kawabori, MD, Chitaru Kurihara, MD, Tadahisa.

Use of Amiodarone After Major Lung Resection

Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease: Implications for future guidelines Andrew B.

Michael Lanuti, MD, Pierre E

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.

Role of Surgical Ventricular Restoration in the Treatment of Ischemic Cardiomyopathy Jun Liu, MD, Zixiong Liu, MD, Qiang Zhao, MD, Anqing Chen, MD, Zhe.

Interaction of Donor and Recipient Age: Do Older Heart Transplant Recipients Require Younger Hearts? Malini Daniel, MD, Carol Chen, MD, Jennifer Chung,

Colonization With Multiresistant Bacteria: Impact on Ventricular Assist Device Patients Maria Papathanasiou, MD, Julia Pohl, MD, Rolf Alexander Jánosi,

Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality Edward L. Hannan, PhD, Zaza Samadashvili,

Right Heart Dysfunction After Left Ventricular Assist Device Implantation: A Comparison of the Pulsatile HeartMate I and Axial-Flow HeartMate II Devices

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Erik N. Sorensen, PhD, Richard N. Pierson, MD, Erika D

Aortic Regurgitation With Markedly Reduced Left Ventricular Function Is Not a Contraindication for Aortic Valve Replacement Tsuyoshi Kaneko, MD, Julius.

A. Thomas Pezzella, MD, Sari D

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Attila Dubecz, MD, Thomas J. Watson, MD, Daniel P

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Left Ventricular Reconstruction Benefits Patients With Dilated Ischemic Cardiomyopathy Atsushi Yamaguchi, MD, Hideo Adachi, MD, Koji Kawahito, MD, Seiichiro.

The Annals of Thoracic Surgery

Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,

Invited Commentary The Annals of Thoracic Surgery

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices Forum Kamdar, MD, Ranjit John,

Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy Ranjit.

Farhan Zafar, MD, John L. Jefferies, MD, MPH, Christine J

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Comparing Aortic Root Replacements: Porcine Bioroots Versus Pericardial Versus Mechanical Composite Roots: Hemodynamic and Ventricular Remodeling at Greater.

Y. Joseph Woo, MD, Michael A. Acker, MD The Annals of Thoracic Surgery

Use of Ventricular Assist Devices in Children Across the United States: Analysis of 7.5 Million Pediatric Hospitalizations David L.S. Morales, MD, Farhan.

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support Peter B. Manning, MD, Michael J. Rutter, MD,

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

Presentation transcript:

Ventricular Assist Device Implant in the Elderly Is Associated With Increased, but Respectable Risk: A Multi-Institutional Study Pavan Atluri, MD, Andrew B. Goldstone, MD, Dale M. Kobrin, BA, Jeffrey E. Cohen, MD, John W. MacArthur, MD, Jessica L. Howard, BS, Mariell L. Jessup, MD, J. Eduardo Rame, MD, Michael A. Acker, MD, Y. Joseph Woo, MD The Annals of Thoracic Surgery Volume 96, Issue 1, Pages 141-147 (July 2013) DOI: 10.1016/j.athoracsur.2013.04.010 Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Age range at time of left ventricular assist device implant. The Annals of Thoracic Surgery 2013 96, 141-147DOI: (10.1016/j.athoracsur.2013.04.010) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier analysis demonstrating cumulative survival for patients less than 70 and 70 or greater years of age undergoing continuous flow left ventricular assist device implant. The Annals of Thoracic Surgery 2013 96, 141-147DOI: (10.1016/j.athoracsur.2013.04.010) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions